Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Unknown 1Not yet recruiting 1Completed 1Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Carcinoma, Non-Small-Cell Lung 72Lung Neoplasms 9Adenocarcinoma of Lung 7Brain Neoplasms 5Non-squamous Non-small Cell Lung Cancer 4NSCLC 4Adenocarcinoma 4Mesothelioma, Malignant 3Colorectal Neoplasms 3Nonsquamous Non-Small Cell Lung Cancer 2Non-squamous Cell Non-Small Cell Lung Cancer 2Neoplasms 2Meningeal Carcinomatosis 2Lymphoma 2Glioma 2Central Nervous System Neoplasms 2Urinary Bladder Neoplasms 1Ureteral Neoplasms 1Untreated Advanced Non-Small Cell Lung Cancer 1Unresectable Stage III NSCLC 1Thyroid Neoplasms 1Thyroid Carcinoma, Anaplastic 1Thoracic Neoplasms 1Stomach Neoplasms 1Stereotactic Radiotherapy; Evoximab (AK112); New Adjuvant Therapy for Non-small Cell Lung Cancer 1Staging IV NSCLC 1Squamous Cell Lung Cancer 1Squamous Cell Carcinoma of Head and Neck 1Solid Tumor 1Respiratory Tract Neoplasms 1

Interventions

spartalizumab 3Injections 3toripalimab 2camrelizumab 2anlotinib 2Therapeutics 2Cisplatin 2Capecitabine 2tislelizumab 1pembrolizumab 1fludarabine 1donafenib 1Pemetrexed 1PM 01183 1Leucovorin 1Irinotecan 1Injections, Intravenous 1Gemcitabine 1Fluorouracil 1Cyclophosphamide 1Carboplatin 15'-Nucleotidase 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Advanced Solid Tumor × Pemetrexed × Clear all
NCT05794477 2023-06-02

A Study of SHR-1802 in Combination With Adebrelimab in Patients With Advanced Solid Tumors

Shanghai Hengrui Pharmaceutical Co., Ltd.

Phase 1/2 Unknown
132 enrolled
Other solid neoplasm

Advanced Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡